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Abstract
Pandemic 2009 influenza A virus (A/H1N1/2009) has emerged globally. In this study, we performed a comprehensive
detection of potential pathogens by de novo sequencing using a next-generation DNA sequencer on total RNAs extracted
from an autopsy lung of a patient who died of viral pneumonia with A/H1N1/2009. Among a total of 9.4610
6 40-mer short
reads, more than 98% appeared to be human, while 0.85% were identified as A/H1N1/2009 (A/Nagano/RC1-L/2009(H1N1)).
Suspected bacterial reads such as Streptococcus pneumoniae and other oral bacteria flora were very low at 0.005%, and a
significant bacterial infection was not histologically observed. De novo assembly and read mapping analysis of A/Nagano/
RC1-L/2009(H1N1) showed more than6200 coverage on average, and revealed nucleotide heterogeneity on hemagglutinin
as quasispecies, specifically at two amino acids (Gly172Glu and Gly239Asn of HA) located on the Sa and Ca2 antigenic sites,
respectively. Gly239 and Asn239 on antigenic site Ca2 appeared to be minor amino acids compared with the highly
distributed Asp239 in H1N1 HAs. This study demonstrated that de novo sequencing can comprehensively detect pathogens,
and such in-depth investigation facilitates the identification of influenza A viral heterogeneity. To better characterize the A/
H1N1/2009 virus, unbiased comprehensive techniques will be indispensable for the primary investigations of emerging
infectious diseases.
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Introduction
In April 2009, an H1N1 triple-reassortant swine influenza virus
(A/H1N1/2009) was detected in humans with febrile respiratory
illness in North America [1], and the virus has rapidly spread
worldwide by human-to-human transmission. According to the
disease outbreak news from the World Health Organization, at
least 14,711 people died from A/H1N1/2009 between April 2009
and January 2010 (http://www.who.int/csr/don/en/). Fatal cases
from A/H1N1/2009 viral infection were summarized in a report
by Gill et al. [2].
The genome of influenza A virus (family Orthomyxoviridae)
consists of 8 single-stranded negative sense RNA molecules
spanning approximately 13.5 kb. The segments range in length
from 890 to 2341 nucleotides (nt) and encode a total of 11 proteins
[3]. Genetic diversity in influenza virus results from a high
mutation rate associated with replication using a low-fidelity RNA
polymerase and the reshuffling (reassortment) of segments among
coinfecting strains. Multiple-reassortant influenza viruses from
avian, human, and swine origins emerged as major pandemic
influenza viruses (i.e., 1918 H1N1, 1957 H2N2, and 1968 H3N2)
causing significant mortality in humans in the 20
th century [4].
Such an ‘‘antigenic shift’’ by multiple reassortant drives the
emergence of pandemic influenza viruses, with their severity and
clinical outcome always unpredictable [5].
Influenza A virus can evade antibodies specific to its attachment
protein, hemagglutinin (HA), by the accumulation of amino acid
substitutions in HA epitopes [6]. This ‘‘antigenic drift’’ in HA
epitopes [7] affects recognition by antibodies that neutralize viral
infectivity by blocking the interaction of HA with sialic acid
residues on host-cell membranes. The H1 subtype HA has four
antigenic sites recognized by monoclonal antibodies with high
neutralizing activity, designated Sa, Sb, Ca, and Cb [8]. In
addition, 8 continuous B cell/antibody epitopes for human H1N1
HA proteins have been experimentally defined by the Immune
Epitope Database and Analysis Resource (IEDB: http://www.
immuneepitope.org/) [9]. Immune epitope analysis of HA
epitopes in A/H1N1/2009 is also summarized in the Influenza
Research Database (http://www.fludb.org/brc/homeExtraPage.
do?decorator=influenza&extraPage=separate) [10].
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characterization of possible antigenic drift will be indispensable.
Igarashi et al. and Shen et al. reported that a structural comparison
of HAs could predict probable future antigenic changes during the
evolution of A/H1N1/2009 in the human population [11,12].
In addition to this prediction, extensive investigations on viral
quasispecies will be required to reveal the actual appearance of
those antigenic changes. Nakamura et al. demonstrated the direct
detection of potential pathogens, including influenza virus, using
de novo pyrosequencing [13], but the detection appeared to have
insufficient redundant sequencing reads to reveal the genetic
variation of the viruses. Ramakrishnan et al. demonstrated the
discrimination of quasispecies in mixed HA subtype infections of
influenza A virus using the same pyrosequencing approach [14].
However, it was shown that the influenza viral RNA sample
should be enriched through sequence-specific oligonucleotide
capturing prior to pyrosequencing, indicating that such enrich-
ment might represent a biased result.
Here, we performed de novo sequencing using total RNAs
extracted from an autopsy lung of a patient infected with A/
H1N1/2009, and detected potential pathogens such as bacteria in
addition to A/H1N1/2009. Extensive DNA sequencing using the
Illumina Genome Analyzer II (GA II) revealed that quasispecies
for the HA sequence were generated in single patient. Such
heterogeneity demonstrated the antigenic drift of HA, implying
the existence of a mechanism to escape pre-existing human
immunity to the virus.
Results
Summary of sequencing reads and detection of potential
pathogens
To determine the influenza A virus sequence and other
potential pathogens, we performed de novo sequencing of double-
stranded cDNA from total RNA extracted from the autopsy lung
of a patient infected with the A/H1N1/2009 virus (A/Nagano/
RC1/2009(H1N1)) in August 2009 in Japan. The patient was
found to be positive for A/H1N1/2009 by real-time reverse
transcriptase-polymerase chain reaction (RT-PCR); histopatho-
logical findings were also reported [15]. GA II produced 9.4610
6
40-mer reads from the cDNA library (Fig. 1B). To exclude the
human-derived read sequences, we performed an analysis pipeline
as follows (Fig. 1A). Initially, all 9,475,890 reads were aligned to a
reference sequence of human genomic DNA, followed by quality
trimming to remove low-quality reads and excluding reads with
similarities to ambiguous human sequences, resulting in 9,309,538
reads (98.24%) with a possible human source (Fig. 1B). The
remaining 166,352 reads (1.75%) were further analyzed using a
BLAST search against non-redundant databases, revealing 80,827
(0.85%), 469 (0.005%), and 85,056 (0.90%) reads as influenza A
virus, bacteria, and no hits, respectively (Fig. 1B).
Regarding the bacterial hits, species classification was deter-
mined based on the results of a BLASTN search against the nt
database (Fig. 1C). The most abundant bacterium was Propioni-
bacterium acnes, but our other sequencing trials for clinical
specimens suggest that this species is always detected (data not
shown). Therefore, the presence of P. acnes could be the result of
contamination at some point from the autopsy to the preparation
of the cDNA library. In addition to P. acnes, Escherichia coli and
Acinetobacter baumannii were frequently detected as possible
contaminants. Suspected bacterial pathogens were identified as
Streptococcus pneumoniae and Porphyromonas gingivalis. Specific PCR
using 16S-rDNA and the lytA gene was performed for further
verification of the presence of S. pneumoniae (data not shown).
Although S. pneumoniae was not sufficiently abundant to conclude a
coinfection with A/H1N1/2009, the severity of the A/H1N1/
2009 infection could be correlated with S. pneumoniae, as reported
by Palacios et al [16]. The other detected bacteria, such as
Streptococcus sp., generally constitute the normal human oral flora.
de novo assembly of the A/H1N1/2009 virus
Whole 40-mer short reads, including human-derived reads,
were assembled using Euler-SR or the Velvet de novo assembler.
The resultant contigs generated using Euler-SR had longer
extended sequences than those generated using Velvet (data not
shown); thus, all further analyses were performed using the contigs
generated using Euler-SR (Texts S1 and S2). All contigs showed
high similarity to the sequences of A/H1N1/2009 (Table 1).
Among the 8 segments, almost the whole lengths of segments 2
(2321 nt), 3 (2231 nt), 4 (1765 nt), 5 (1562 nt), 7 (1026 nt), and 8
(892 nt) were correctly assembled as single contigs of 2204, 2198,
1761, 1514, 1019, and 834 nt, respectively (Table 1 and Fig. 2).
Segments 1 and 6 were divided into several contigs, but were
correctly aligned to the known sequences (Table 1 and Fig. 2).
Read mapping analysis of the A/H1N1/2009 virus
To obtain whole sequences and identify single nucleotide
polymorphisms (SNPs) for the 8 segments, the 40-mer short reads
were aligned to the sequence of A/Tronto/T0106/2009(H1N1),
which was found to be the most similar to the A/H1N1/2009
virus using a BLASTN search. Figure 2 shows dot plot images of
the coverage at every nucleotide of the segments. Read coverage
was observed at ,6200 on average for all segments, indicating a
sufficient redundancy to identify the viral sequences and SNPs.
The obtained viral sequences, designated as A/Nagano/RC1-L/
2009(H1N1), were consistent with those from A/Nagano/RC1/
2009(H1N1) passaged in the Madin-Darby canine kidney
(MDCK) cell line, except for 3 possible heterogeneous nucleotides
in HA.
The coverage plot curves were not flat throughout the segments.
Intriguingly, both ends of segment 1 (encoding PB2), the 39–end of
segment 3 (encoding PA), and approximately 700 nt of segment 8
(encoding NS) showed significant abundant coverage greater than
61000.
Genetic population analysis of the A/H1N1/2009 virus
To identify heterogeneous populations, alignment results were
screened using MapView software (Fig. 3B). Three potential
heterogeneous genetic populations were found in segment 4
(encoding HA) at the 515, 715, and 716 nt positions (Fig. 3A), but
not in other segments. The read alignments shown in Fig. 3B
indicate that either the GGT or AAT sequence appeared at the
715–717 nt position, but not the GAT or AGT sequence. In
addition, the read coverage implied that the major (GG; HA-
Major) or minor (AA; HA-Minor) nucleotides were detected at the
frequencies of 75% and 25%, respectively. To validate these
variations, HA-Major- or HA-Minor-specific quantitative RT-
PCR (qRT-PCR) was performed for the preparation of specific
PCR products between the 434 and 738 nt in the HA coding
sequence (Fig. 3C). qRT-PCR demonstrated that the expression of
HA was ,40,000-fold greater than that of human b-actin, and the
expression ratio of HA-Major/HA-Minor was 4.05, suggesting
that it corresponds to the read mapping shown in Fig. 3A.
Furthermore, HA-Major and HA-Minor sequences were verified
by Sanger DNA sequencing of the specific PCR products (Fig. 3D).
Taken together, these results suggest the following amino acid
substitutions of HA: one nucleotide alteration causes Gly172Glu
and the other two alterations cause Gly239Asn (Fig. 3D).
Quasispecies of A/H1N1/2009
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To elucidate whether the Gly172Glu and Gly239Asn amino acid
substitutions in the HA sequence could be associated with
antigenic drift, they were compared to known potential epitopes
[8,9]. Representative HA amino acid sequences of the H1N1
influenza A virus were aligned with the heterogeneous HA-Major
and HA-Minor sequences. The Gly172Glu substitution (corre-
sponding to Gly158 in the mature HA lacking a signal peptide)
was located on the Sa antigenic site (Fig. 4A).
The HA Gly172Glu substitution is likely to be rare thus far
because a BLASTP search against the non-redundant nr database
revealed only two identical hits, A/Bayern/62/2009(H1N1) in
Germany and A/Catalonia/S1207/2009(H1N1) in Spain (data
not shown). One intriguing hit was to A/Pennsylvania/14/
2009(H1N1) isolated in the US, whose HA sequence has an Xaa
amino acid at position 172 due to the presence of the
heterogeneous nucleotide R (A or G) (Fig. 5A). This deposited
sequence completely coincides with our observation, suggesting
that two variants of HAs are likely to coexist in the human lung,
further implying that such heterogeneous populations might
frequently be generated during infection.
Furthermore, HA Gly239Asn was located on the Ca2 antigenic
site that contributes to binding with the host’s sialic acid receptor
[17]. Asp239 (corresponding to Asp225 in the mature HA lacking
a signal peptide) was frequently distributed in H1N1 HAs (Fig. 4B),
but Gly239 and Asn239 were found to be minor amino acids
among HAs; a BLASTN search found 18 and 5 hit entries on the
nt database, respectively. As was observed for Gly172, Xaa239
Figure 1. Detection of potential pathogens by comprehensive de novo sequencing. (A) Schematic representation of the analysis pipeline
for the detection of pathogens from comprehensive sequencing of human clinical specimens. After excluding human-derived DNA sequences using
Maq software and a BLAST homology search against human genomic DNA and human ambiguous sequences extracted from the nt database, the
remaining short reads were subjected to a BLAST search to detect potential pathogens. (B) Pie chart of the homology search results for the 40-mer
short reads. Read numbers and their percentage to the total reads are shown in parenthesis. (C) Pie chart of identified bacterial hits. Number of hit
reads is shown in parenthesis. Bacteria with less than 5 hit reads were excluded.
doi:10.1371/journal.pone.0010256.g001
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heterogeneity of both minor amino acids may affect its binding
affinity to the sialic acid receptor.
Discussion
In this study, we demonstrated the detection of potential
pathogens using a next-generation DNA sequencer. We speculated
that, in addition to influenza A virus, additional potential
pathogens such as S. pneumoniae could contribute to the severity
and fatality of infection with the A/H1N1/2009 virus [2,16]. In
this case, the amount of bacteria detected was small (Fig. 1B and
1C), and they were considered to be the result of contamination
during the course of the experiment, from autopsy to short read
sequencing. The clinical outcome of the patient and histopatho-
logical examination suggest that this was a case of influenza viral
pneumonia rather than bacterial infection [15], although S.
pneumoniae coinfection has been reported to play a crucial role in
the severity of influenza virus infection in some cases [16,18].
In the present autopsy lung sample, very significant viral copies
(,40,000-fold greater than b-actin) were determined using qRT-
PCR, but this was not always observed in autopsy samples from
other patients (less than b-actin) (data not shown). Such abundant
read sequencing enabled us to obtain almost full-coverage contig
sequences for the viral segments using de novo assembly, suggesting
the importance of this result in terms of being able to evaluate
uncharacterized emerging infectious agents using an unbiased
sequencing technique at the outbreak of a pandemic. Indeed, this
study demonstrated that whole contigs can be identified as A/
H1N1/2009, but not seasonal H1N1 or other subtypes (Table 1).
The read coverage profile generated by mapping was very
indicative for segment 1 encoding PB2 (Fig. 2). Both ends were
highly redundant with up to 63000 coverage. The coverage is
reflected by the amounts of vRNA, cRNA, and mRNA of
influenza A virus, implying that the coverage bias may detect a
more stable region as it is dependent on the expression level or
manner of replication.
Contrary to the viral sequences obtained for A/Nagano/RC1/
2009(H1N1) isolated from passaging in MDCK cells, de novo
sequencing revealed the presence of A/Nagano/RC1-L/
2009(H1N1) HA quasispecies in the autopsy sample (Fig. 3).
Despite the fact that immunity to A/H1N1/2009 viruses is
supposed to be limited among the general human population [19],
we detected the amino acid substitution Gly172Glu in the HA Sa
antigenic site in A/Nagano/RC1-L/2009(H1N1), and this
appears to be a very rare event among A/H1N1/2009 viruses
to date.
We also observed another substitution of Gly239Asn in the HA
Ca2 antigenic site of A/Nagano/RC1-L/2009(H1N1). This
antigenic site plays a crucial role in conferring specificity to
galactose of the human a2-6 sialylated glycan receptor [20].
Interestingly, Asp239 (corresponding to Asp225 in the mature HA
that lacks a signal peptide) is highly prevalent in known H1N1
HAs, indicating that both Gly239 and Asn239 appear to be very
minor amino acids among all HA sequences.
Thus far, amino acid substitutions in the HAs of A/H1N1/2009
have been identified compared with seasonal H1N1 HAs.
Homology-based structural investigations [17,21] suggest that A/
H1N1/2009 HA has the necessary residues to provide optimal
contacts for high affinity binding to a2-6 sialylated glycans present
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.826 183 2835 183 1 gb|GQ328865|INFLUENZA A virus (A/Finland/553/
2009(H1N1)) segment 1 polymerase PB2 (PB2)
2345 167/168 (99%) 5–168
.324 1558 136 1558 1 gb|GQ365425|INFLUENZA A virus (A/Fukushima/1/
2009(H1N1)) segment 1 polymerase PB2 (PB2)
2280 1556/1558 (99%) 201–1758
.1194 239 112 239 1 gb|GQ894926|INFLUENZA A virus (A/Delaware/03/
2009(H1N1)) segment 1 polymerase PB2 (PB2)
2280 214/214 (100%) 1894–2107
.887 174 3294 174 1 gb|GQ894833|INFLUENZA A virus (A/Rhode Island/08/
2009(H1N1)) segment 1 polymerase PB2 (PB2)
2280 156/156 (100%) 2145–2300
.890 2204 4651 2204 2 gb|GQ894924|INFLUENZA A virus (A/New Mexico/04/
2009(H1N1)) segment 2 polymerase PB1 (PB1)
2274 2200/2204 (99%) 41–2244
.696 2198 3968 2198 3 gb|GQ866924|INFLUENZA A virus (A/Thailand/CU-H106/
2009(H1N1)) segment 3 polymerase PA (PA)
2238 2152/2155 (99%) 54–2208
.868 1761 3831 1761 4 gb|CY045503|INFLUENZA A virus (A/Bayern/66/
2009(H1N1)) segment 4 sequence
1754 1750/1754 (99%) 1–1741
.897 1514 1710 1514 5 gb|GQ502907|INFLUENZA A virus (A/Toronto/R8557/
2009(H1N1)) segment 5 nucleocapsid protein
1558 1511/1514 (99%) 36–1549
.224 101 9 101 6 gb|GQ502908|INFLUENZA A virus (A/Toronto/R8557/
2009(H1N1)) segment 6 neuraminidase (NA)
1458 101/101 (100%) 3–103
.1206 1302 2468 1302 6 gb|GQ906584|INFLUENZA A virus (A/Stockholm/49/
2009(H1N1)) segment 6 neuraminidase (NA)
1447 1299/1300 (99%) 124–1423
.750 1019 1128 1019 7 gb|CY045957|INFLUENZA A virus (A/Toronto/T0106/
2009(H1N1)) segment 7 sequence
1026 1017/1017 (100%) 9–1025
.809 834 4399 834 8 gb|GQ485660|INFLUENZA A virus (A/Ekaterinburg/01/
2009(H1N1)) segment 8 nuclear export
877 828/830 (99%) 52–881
Schematic representation of contigs is shown in Fig. 2.
doi:10.1371/journal.pone.0010256.t001
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minimal contact with a2-3 sialylated glycans present in the human
lower respiratory tract [23]. Indeed, the recombinant A/H1N1/
2009 HA has been characterized to exhibit lower binding to the
alveolar tissue of the lower respiratory tract [17]. However, we
previously detected abundant viral nucleoprotein of A/Nagano/
Figure 2. Dot plot of short read coverage (Cov.) at every nucleotide for the 8 segments of A/Nagano/RC1-L/2009(H1N1). To obtain
the consensus sequences for the respective 8 segments, 40-mer short reads were aligned to the complete segment sequences of A/Tronto/T0106/
2009(H1N1) (gb|CY045951.1 – .8). Short read sequencing was performed using total RNA including human RNA, and also vRNA, cRNA, and mRNA
from influenza A virus; thus, coverage bias was detected throughout the segments, but the average coverage (AC) is likely to be similar at
approximately 6200 or more. The horizontal red arrows show the location of the contigs obtained by de novo assembly, as shown in Table 1.
doi:10.1371/journal.pone.0010256.g002
Figure 3. Genetic variations of the HA nucleotide sequence. (A) Schematic representation of 3 nucleotide variations (positions 515, 715, and
716 nt) in the HA coding nucleotide sequence. Three variations were classified as Major (75% appearance) or Minor (25% appearance) by read
coverage (6), and the coding amino acids are also shown. (B) Arrows indicate positions 715 and 716 nt of the HA sequence, and the alignment image
of the 40-mer reads. Nucleotides shown in red are the mismatches to the reference sequence of A/Tronto/T0106/2009(H1N1). Every read suggested
that either the GGT or AAT sequence was present, but not the GAT or AGT sequence. (C) An amplification plot for HA-specific qRT-PCR. (D) Validation
of genetic variation by Sanger capillary sequencing. HA-Major or HA-Minor PCR products were obtained by qRT-PCR using HA-Major- or HA-Minor-
specific PCR primers. HA-Major PCR product shows G nucleotides at positions 515, 715, and 716 nt, while HA-Minor shows A nucleotides.
doi:10.1371/journal.pone.0010256.g003
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glycans in autopsy lung tissue sections [15], suggesting that the
above substitutions could affect the binding affinity to both types of
sialylated glycans.
Very suggestive reports predicted the possible future antigenic
drift of A/H1N1/2009 viruses from viral sequence and structural
comparative analyses [11,12]. Prior to the initiation of the current
study (September 2009), Igarashi et al. predicted possible
substitutions and these included the two amino acid substitutions
presented here (Gly172Glu and Asp239Gly) [11]. Furthermore,
Shen et al. suggested that host-driven antigenic drift based on
evolutionary trends appeared to favor Asp239 (corresponding to
Asp225 in the mature HA) in swine HAs and the 1918 pandemic,
while Asp204 (corresponding to Asp190 in the mature HA) was
favored in seasonal H1N1 HAs [12]. These predictions are very
attractive and our experiments demonstrated one of them a
posteriori. Furthermore, recent study has shown that receptor-
binding avidity can influence antigenic drift [24]. HA antigenic
sites Sa is the membrane proximal region, therefore, the identified
variations on both Sa and Ca2 might contribute to the alteration
of antigenicity and receptor-binding avidity by synergistic effect.
The newly identified Asn239 substitution could be a probable
candidate for further investigation of the manner of viral binding
to sialic acid on the host receptors.
In conclusion, this study demonstrated that de novo sequencing
can comprehensively detect pathogens, and such in-depth
Figure 4. Alignment of HA amino acid sequences in influenza A virus around the identified mutations in A/Nagano/RC1-L/
2009(H1N1). (A) Genetic variation at position 515 nt causes the amino acid substitution Gly172Glu; HA-Major: Gly172, HA-Minor: Glu172. (B) Genetic
variation at position 715 and 716 nt causes the amino acid substitution Gly239Asn; HA-Major: Gly239, HA-Minor: Asn239.
doi:10.1371/journal.pone.0010256.g004
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heterogeneity during infection. The possibility of mixed infections
with variants remains to be elucidated in this case, but worldwide
sequencing efforts suggest that quasispecies of the A/H1N1/2009
virus evidently appear and are observed. To better characterize
the currently emerging A/H1N1/2009 virus and prevent worse
pandemics in the near future, unbiased de novo sequencing




The study protocol was approved by the institutional medical
ethical committee, National Institute of Infectious Diseases, Japan
(Approval No.236), and the study was conducted according to the
Declaration of Helsinki Principles. In the autopsy case, a written
consent for autopsy was obtained from relatives.
Total RNA and cDNA preparation from autopsy human
lung
Information for the patient was previously reported [15].
Briefly, in August 2009, a 33-year-old male patient with chronic
heart failure due to dilated cardiomyopathy, mild diabetes
mellitus, atopic dermatitis, asthma, and obesity (BMI: 38) died
from respiratory failure and multiple organ dysfunction syndrome.
A diagnosis of pandemic influenza A virus (A/H1N1/2009)
infection was determined using RT-PCR testing in a clinical
laboratory. Total RNA was prepared from a 5-mm cube of the
autopsy lung tissue using ISOGEN (NipponGene, Japan), followed
by Ambion TurboDNase treatment (Ambion, Austin, TX USA).
Double-stranded cDNA was prepared from 5 mg of total RNA
using the random priming method with SuperScript Choice
System for cDNA synthesis (Invitrogen, Carlsbad, CA, USA).
cDNA was purified using a QIAquick PCR Purification kit
(QIAGEN, Hilden, Germany).
Short-read DNA sequencing using the Illumina Genome
Analyzer II
An approximately 300-bp length cDNA library was prepared
using a genomic DNA sample prep kit (Illumina, San Diego, CA,
USA), and DNA clusters were generated on a slide using a Cluster
Generation kit (ver. 2) on an Illumina cluster station (Illumina),
according to the manufacturer’s instructions. To obtain ,1.0610
7
clusters for one lane, the general procedure as described in the
standard recipe (Illumina) was performed as follows: template
hybridization, isothermal amplification, linearization, blocking,
denaturation, and hybridization of the sequencing primer
(Illumina). All sequencing runs for 40 mers were performed with
GA II using the Illumina Sequencing kit (ver. 3). Fluorescent
images were analyzed using the Illumina base-calling pipeline
1.4.0 to obtain FASTQ formatted sequence data.
Homology search analysis
The obtained DNA sequences were investigated using a BLAST
search as shown in Fig. 1A. The results of the BLASTN search
were analyzed and visualized using MEGAN v3.7.4 [25] with the
following parameters: minimum support, 5; minimum score, 35.0.
de novo assembly of short reads
Prior to de novo assembly, all obtained 40-mer reads were
trimmed based on the phred quality value obtained using the Euler-
SR qualitytrimmer command [26]. Such trimmed read sequences
were assembled using Velvet v0.7.55 [27] or Euler-SR v1.0 [26]
with the default parameters (Velvet: hash length, 25; Euler-SR:
vertex size, 25).
Read mapping
To obtain consensus sequences for the respective 8 segments of
influenza A virus, 40-mer short reads were aligned to A/Tronto/
T0106/2009(H1N1) sequences (gb|CY045951.1 – .8) as reference
sequences with Maq software (ver. 0.7.1) [28] using the easyrun
Perl-command. The consensus sequences were extracted as a
‘‘cns.fq’’ file for each segment, and deposited in the DNA Data
Bank of Japan (DDBJ; accession numbers: AB538386 to
AB538393 for the 8 segments of A/Nagano/RC1-L/
2009(H1N1), and AB538394 for segment 4 encoding the HA-
Minor sequence). Read coverage at every nucleotide was obtained
using Maq software (ver. 0.7.1) with the pileup command. Read
alignment for the validation of SNPs was performed using the
MapView graphical alignment viewer [29].
qRT-PCR analysis
qRT-PCR was performed using 100 ng of total RNA, HA
variant-specific primers (forward common primer: pdmFlu09-HA-
F, 59–CGAACAAAGGTGTAACGGCAGCAT–39; HA-Major-
specific reverse primer: pdmFlu-HA-R_Major, 59–ATAGTT-
CATTCTCCCTTCTTGACC–39; HA-Minor-specific reverse
primer: 59–ATAGTTCATTCTCCCTTCTTGATT–39), and
Figure 5. BLAST homology search of the HA sequences against
the nr or nt databases. (A) Glu172 of HA-Minor. (B) Gly239 of HA-
Major. R: A or G.
doi:10.1371/journal.pone.0010256.g005
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kit with ROX (Invitrogen), and analyzed using the ABI PRISM
7900HT Real-time PCR System (Applied Biosystems, Foster City,
CA, USA). The following qRT-PCR program was used: RT
reaction, 50uC for 3 min; initial denaturation, 95uC for 5 min; 2
steps of amplification (640 cycles), 95uC for 15 sec and 60uC for
30 sec. The human b-actin gene was used as the internal control.
PCR products were resolved by 5% polyacrylamide gel electro-
phoresis, followed by Sanger sequencing using the BigDye
Terminator v3.1 Cycle Sequencing kit (Applied Biosystems).
Virus isolation
The A/H1N1/2009 virus was isolated from MDCK cells
passaged once with trypsin.
Supporting Information
Text S1 Fastq file of the 40-mer short reads with similarity to
influenza A virus extracted from whole obtained short reads.
Found at: doi:10.1371/journal.pone.0010256.s001 (11.19 MB
PDF)
Text S2 De novo assembly of the influenza A virus using Euler-
SR v1.0 [26] with the default parameters (vertex size, 25).
Found at: doi:10.1371/journal.pone.0010256.s002 (0.04 MB
RTF)
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